JCI Insight (Feb 2022)

Human CD206+ macrophages associate with diabetes and adipose tissue lymphoid clusters

  • Lindsey A. Muir,
  • Kae Won Cho,
  • Lynn M. Geletka,
  • Nicki A. Baker,
  • Carmen G. Flesher,
  • Anne P. Ehlers,
  • Niko Kaciroti,
  • Stephen Lindsly,
  • Scott Ronquist,
  • Indika Rajapakse,
  • Robert W. O’Rourke,
  • Carey N. Lumeng

Journal volume & issue
Vol. 7, no. 3

Abstract

Read online

Increased adipose tissue macrophages (ATMs) correlate with metabolic dysfunction in humans and are causal in development of insulin resistance in mice. Recent bulk and single-cell transcriptomics studies reveal a wide spectrum of gene expression signatures possible for macrophages that depends on context, but the signatures of human ATM subtypes are not well defined in obesity and diabetes. We profiled 3 prominent ATM subtypes from human adipose tissue in obesity and determined their relationship to type 2 diabetes. Visceral adipose tissue (VAT) and s.c. adipose tissue (SAT) samples were collected from diabetic and nondiabetic obese participants to evaluate cellular content and gene expression. VAT CD206+CD11c− ATMs were increased in diabetic participants, were scavenger receptor–rich with low intracellular lipids, secreted proinflammatory cytokines, and diverged significantly from 2 CD11c+ ATM subtypes, which were lipid-laden, were lipid antigen presenting, and overlapped with monocyte signatures. Furthermore, diabetic VAT was enriched for CD206+CD11c− ATM and inflammatory signatures, scavenger receptors, and MHC II antigen presentation genes. VAT immunostaining found CD206+CD11c– ATMs concentrated in vascularized lymphoid clusters adjacent to CD206–CD11c+ ATMs, while CD206+CD11c+ were distributed between adipocytes. Our results show ATM subtype–specific profiles that uniquely contribute to the phenotypic variation in obesity.

Keywords